Editor’s note

The recent faulty hip implant episode proves that our laws have not evolved as fast as medical technology

While there are good intentions, it is the implementation which threatens the viability of  initiatives like the Pharm D course…

Most bigger pharma companies have moved to the next level of exports: the trade of intellectual property, in the form of clinical…

In my Editors Note in last year's Independence Day special issue, I had asked: as we mark our 71st Independence Day this August…

It is ironical that a Chinese movie seems to have done what India's policy makers have been trying to do for many years: get China…

One of the important proposals considered during the 79th Drug Technical Advisory Board (DTAB) meeting held on May 16 was the…

It’s time to count the learnings from Halol, both internally for Sun Pharma as well as for India Pharma Inc

In a speech on May 12, US President Donald Trump put one of his most populist election promises — to make medicines more…

For the past two years, the May 16-31 edition of Express Pharma has been a GMP Special issue, highlighting topics crucial to…

The task force on APIs is too late to rescue Orchid Pharma but will hopefully prevent more API makers from burning out.